These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis. Refardt J; Winzeler B; Christ-Crain M Clin Endocrinol (Oxf); 2019 Jul; 91(1):22-32. PubMed ID: 31004513 [TBL] [Abstract][Full Text] [Related]
26. Influence of sodium-glucose Co-transporter 2 inhibitors on clinical and biochemical markers of dehydration during the Holy Ramadan. Gameil MA; Marzouk RE; El-Sebaie AH; Eldeeb AAA Diabetes Metab Syndr; 2022 Sep; 16(9):102606. PubMed ID: 36063675 [TBL] [Abstract][Full Text] [Related]
27. Arginine Vasopressin and Copeptin in Perinatology. Evers KS; Wellmann S Front Pediatr; 2016; 4():75. PubMed ID: 27532032 [TBL] [Abstract][Full Text] [Related]
28. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Boertien WE; Meijer E; Li J; Bost JE; Struck J; Flessner MF; Gansevoort RT; Torres VE; Am J Kidney Dis; 2013 Mar; 61(3):420-9. PubMed ID: 23089511 [TBL] [Abstract][Full Text] [Related]
29. Vasopressin but Not Oxytocin Responds to Birth Stress in Infants. Fill Malfertheiner S; Bataiosu-Zimmer E; Michel H; Fouzas S; Bernasconi L; Bührer C; Wellmann S Front Neurosci; 2021; 15():718056. PubMed ID: 34512251 [TBL] [Abstract][Full Text] [Related]
30. The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases. Nigro N; Müller B; Morgenthaler N; Fluri F; Schütz P; Neidert S; Stolz D; Bingisser R; Tamm M; Christ-Crain M; Katan M Swiss Med Wkly; 2011; 141():w13270. PubMed ID: 21990032 [TBL] [Abstract][Full Text] [Related]
31. Semimechanistic modeling of copeptin and aldosterone kinetics and dynamics in response to rehydration treatment for diabetic ketoacidosis in children. Otto ME; Burckhardt MA; Szinnai G; Pfister M; Gotta V CPT Pharmacometrics Syst Pharmacol; 2023 Feb; 12(2):207-220. PubMed ID: 36510706 [TBL] [Abstract][Full Text] [Related]
37. Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. Simmler LD; Hysek CM; Liechti ME J Clin Endocrinol Metab; 2011 Sep; 96(9):2844-50. PubMed ID: 21715530 [TBL] [Abstract][Full Text] [Related]
38. Elevated plasma levels of copeptin linked to diabetic retinopathy in type 2 diabetes. Zhao Q; Wu XX; Zhou J; Wang X Mol Cell Endocrinol; 2017 Feb; 442():106-112. PubMed ID: 27940301 [TBL] [Abstract][Full Text] [Related]
40. A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis. Fenske W; Sandner B; Christ-Crain M Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):219-33. PubMed ID: 27156760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]